Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2000
08/02/2000EP1023077A1 Opthalmic composition
08/02/2000EP1023075A1 Liquid presentations of oxazaphosphorine-containing pharmaceutical products
08/02/2000EP1023074A1 Methods for treating psychosis associated with glucocorticoid related dysfunction
08/02/2000EP1023073A1 Vitronectin receptor antagonist
08/02/2000EP1023072A1 Analgesic compositions
08/02/2000EP1023071A1 Method for inhibiting development of liver cancer and increasing survival in chronic hepadnavirus infection
08/02/2000EP1023070A1 Use of monoxidine for the treatment of depression
08/02/2000EP1023069A1 Nicotine compositions and methods of formulation thereof
08/02/2000EP1023068A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
08/02/2000EP1023067A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/02/2000EP1023066A1 Novel pyrazole and pyrazoline substituted compounds
08/02/2000EP1023065A1 Granules free of excipients
08/02/2000EP1023064A1 12(s)-hete receptor blockers
08/02/2000EP1023063A1 INDENO 1,2-c]-, NAPHTHO 1,2-c]- AND BENZO 6,7]CYCLOHEPTA 1,2-c]PYRAZOLE DERIVATIVES
08/02/2000EP1023062A1 Antibacterial carbapenems, compositions and methods of treatment
08/02/2000EP1023061A1 Somatostatin agonists
08/02/2000EP1023060A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
08/02/2000EP1023059A2 Pharmaceutical preparations
08/02/2000EP1023058A2 Amelioration of ischemic damage using synthetic oxygen carriers
08/02/2000EP1023057A1 Use of thiazolidinediones for the treatment of hyperglycaemia
08/02/2000EP1023056A1 Use of thiazolidinediones for the treatment of hyperglycaemia
08/02/2000EP1023055A1 Inhibition of crystallization in transdermal devices
08/02/2000EP1023053A1 Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption
08/02/2000EP1023051A1 Oral morphine multiparticulate formulation
08/02/2000EP1023050A1 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
08/02/2000EP1023046A1 Apparatus and method for diluting nasal sprays containing addictive compounds
08/02/2000EP1023040A1 Compositions based on plant extracts
08/02/2000EP1023039A2 Use of alkylmonoglucosides as molecular vectors
08/02/2000EP1023034A1 Cosmetic formulations for the prevention and therapy of hair loss
08/02/2000EP1023031A1 Chemical composition having spermicidal, bactericidal and virucidal activity and apparatus for delivery into the vaginal canal
08/02/2000EP1022960A1 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects
08/02/2000EP1022951A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
08/02/2000EP1022945A2 Method and formulation for treating vascular disease
08/02/2000EP0923642A4 Active survival domains of igf-ir and methods of use
08/02/2000EP0885229B1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
08/02/2000EP0873351B1 Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
08/02/2000EP0828825A4 Methods of use of phthalocyanines to inactivate blood borne parasites
08/02/2000EP0819129B1 Pyrazole derivatives and processes for the preparation thereof
08/02/2000EP0758889B1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients
08/02/2000EP0748222B1 Antitussive composition containing an antitussive and benzydamine
08/02/2000EP0731796B1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
08/02/2000EP0729325A4 Osteogenic product and process
08/02/2000EP0691953B1 1-amidinophenyl-pyrrolidones/ piperidinones as platelet aggregation inhibitors
08/02/2000EP0641208B1 4-azasteroid 5-alpha-reductase inhibitors
08/02/2000EP0613373B1 Risedronate delayed-release compositions
08/02/2000EP0527889B1 Quinolizinone type compounds
08/02/2000CN1261920A Enzymatic DNA molecules
08/02/2000CN1261906A Alkyl, alkenyl and alkynyl chrysamine G derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
08/02/2000CN1261894A Polyol-amino-acid compounds having anti-helicobactor pylori activity
08/02/2000CN1261893A 3'-monophosphorylating oligonucleotides
08/02/2000CN1261892A Diphosphonic acid salts for treatment of osteoporsis
08/02/2000CN1261890A Novel naphthyridine derivatives or salts thereof
08/02/2000CN1261889A Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agent
08/02/2000CN1261888A 2{4-[4-(4,5-dichloro-2-methylimidazol-1-yl) butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and therapeutic use
08/02/2000CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000CN1261886A Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperdylidene)-5H-benzo [5,6] cyclohepta [1,2-b] pyridine
08/02/2000CN1261885A 2-substituted 4,5-diaryl imidazoles
08/02/2000CN1261883A Novel compounds
08/02/2000CN1261882A Polymorphic form of tachykinin receptor antagonist 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl) phenyl) ethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-5(oxo-1H,4H-1,2,4-triazolo methylmorpholine
08/02/2000CN1261881A 6-azauracil derivatives as IL-5 inhibitors
08/02/2000CN1261880A Inhibitors of farnesyl protein transferase
08/02/2000CN1261879A Method for preparing substituted perhydroisoindole
08/02/2000CN1261878A New cysteine derivatives processes for their production, and pharmaceuticals containing them
08/02/2000CN1261877A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
08/02/2000CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
08/02/2000CN1261807A Improved method for transferring nucleic acid into the striped muscle and combination therefor
08/02/2000CN1261804A Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor
08/02/2000CN1261803A Antioxidant enhancement of therapy for hyperproliferative conditions
08/02/2000CN1261801A Allelic polygene diagnosis of reward deficiency syndrome and treatment
08/02/2000CN1261800A Method of treatment of lever tumours and pharmaceutical compositions for use therein
08/02/2000CN1261799A Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
08/02/2000CN1261798A Medicine containing yohimbine and arginine for treating erectile dysfunction
08/02/2000CN1261797A Self-emulsifying formulation forlipophilic compounds
08/02/2000CN1261796A Self-emulsifying formulation for lipophilic compounds
08/02/2000CN1261795A Compounds and methods
08/02/2000CN1261794A Solubilized sertraline compositions
08/02/2000CN1261793A Sertraline salts and substained-release dosage forms of sertraline
08/02/2000CN1261792A Gelatine encapsulated solution dosage forms of sertraline
08/02/2000CN1261791A Targeted liposomal constructs for diagnostic and therapeutic uses
08/02/2000CN1261790A Self-emulsifying formulation for lipophilic compounds
08/02/2000CN1261602A Alcohol derivative of Triperygium wilfordii lactone and its application
08/02/2000CN1261538A External medicine with anti-infections and recovery function
08/02/2000CN1261535A Use of methionine composition in preparation of medicine for curin cardio-cerebral vascular diseases
08/02/2000CN1261534A Medicinal composition containing naphthyl compound
08/02/2000CN1055093C Glucosamine disaccharides, its preparation and use, and pharmaceutical composition comprising same
08/02/2000CN1055090C Crystilline ceftiofur free acid
08/02/2000CN1055089C Intermediate of protein kinase C inhibitor and its preparation
08/02/2000CN1055087C Method and apparatus for extracting taxol from source material
08/02/2000CN1055085C Sacchrin zinc and its producing process
08/02/2000CN1055079C Extraction method for unsaturated fatty acid from fish oil
08/02/2000CN1055016C Powder for removing toxic substances and promoting granulation
08/02/2000CN1054965C Process for preparing phospholipid powder from hydrated oil foot
08/01/2000US6096909 Taxoid anti-tumor agents and pharmaceutical compositions thereof
08/01/2000US6096904 Discodermolides
08/01/2000US6096902 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
08/01/2000US6096897 Endothelin receptor antagonists
08/01/2000US6096888 Anthracyclinone derivatives and their use in amyloidosis
08/01/2000US6096840 Gas phase polymerization process
08/01/2000US6096788 Molecules containing two quaternary ammonium groups on ends of hydrocarbon chain
08/01/2000US6096787 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
1 ... 6270 6271 6272 6273 6274 6275 6276 6277 6278 6279 6280 6281 6282 6283 6284 6285 6286 6287 6288 6289 6290 ... 7860